| Announce Date | 11/24/2025 |
| EPS Normalized Actual | $0.127 (Miss by $-0.463) |
| EPS GAAP Actual | $0.127 (Miss by $-0.463) |
| Revenue Actual | $3.925B |
| Revenue Surprise | Beat by $3925M |
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Oct 2030 | 3.6 | 10.43 | 3.52918 | 3.68423 | 2 |
| Oct 2029 | 3.45 | 10.88 | 3.39664 | 3.50293 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2025 (Oct 2025) | 0.16 | 0.16 | 3.925B | 12.97% | 3925M |
| FQ2 2025 (Jun 2025) | 0.0412 | 0.0412 | 3.561B | 61.86% | 3561M |
| FQ1 2025 (Mar 2025) | 0.189 | 0.189 | 3.491B | 59.18% | 3491M |
| FQ4 2024 (Dec 2024) | 0.28 | 0.28 | 3.416B | 60.1% | 3416M |
| FQ4 2022 (Dec 2022) | 0 | 0 | 1.274B | 100% | 1274M |
| FQ1 2023 (Mar 2023) | 0 | 0 | 1.391B | 100% | 1391M |
| FQ2 2023 (Jun 2023) | 0 | 0 | 1.401B | 100% | 1401M |
| FQ3 2023 (Sep 2023) | 0 | 0 | 1.47B | 100% | 1470M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ3 2028 (Jul 2028) | 0.82 | -- | 0.80685 | 0.84273 | 3 |
| FQ2 2028 (Apr 2028) | 0.76 | -- | 0.74781 | 0.78107 | 3 |
| FQ1 2028 (Jan 2028) | 0.725 | -- | 0.71337 | 0.7451 | 3 |
| FQ3 2027 (Jul 2027) | 0.69576 | -- | 0.6846 | 0.71504 | 2 |
| FQ2 2027 (Apr 2027) | 0.65875 | -- | 0.64818 | 0.67701 | 2 |
| FQ1 2027 (Jan 2027) | 0.61287 | -- | 0.60304 | 0.62986 | 2 |
| FQ4 2026 (Dec 2026) | 0.67 | 76.12 | 0.64719 | 0.68188 | 1 |
| FQ3 2026 (Jul 2026) | 0.61764 | -- | 0.60773 | 0.63476 | 2 |
| FQ2 2026 (Jun 2026) | 0.58 | 92.9 | 0.57504 | 0.58633 | 2 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ3 2028 (Jul 2028) | 3.83B | -- | 3.78B | 3.91B | 2 |
| FQ2 2028 (Apr 2028) | 3.71B | -- | 3.67B | 3.79B | 2 |
| FQ1 2028 (Jan 2028) | 3.59B | -- | 3.55B | 3.67B | 2 |
| FQ3 2027 (Jul 2027) | 3.67B | -- | 3.62B | 3.74B | 3 |
| FQ2 2027 (Apr 2027) | 3.58B | -- | 3.54B | 3.66B | 3 |
| FQ1 2027 (Jan 2027) | 3.45B | -- | 3.41B | 3.52B | 3 |
| FQ4 2026 (Dec 2026) | 3.68B | -6.63 | 3.58B | 3.73B | 1 |
| FQ3 2026 (Jul 2026) | 3.57B | -- | 3.53B | 3.65B | 3 |
| FQ2 2026 (Jun 2026) | 3.61B | 1.25 | 3.58B | 3.64B | 3 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
4
EPS # of Misses
0
EPS # of in-lines
4
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Oct 2025) | 0.16 | 0.16 | 100% | |
| FQ2 2025 (Jun 2025) | 0.0412 | 0.0412 | 100% | |
| FQ1 2025 (Mar 2025) | 0.189 | 0.189 | 100% | |
| FQ4 2024 (Dec 2024) | 0.28 | 0.28 | 100% | |
| FQ4 2022 (Dec 2022) | 0 | 0 | NAN% | |
| FQ1 2023 (Mar 2023) | 0 | 0 | NAN% | |
| FQ2 2023 (Jun 2023) | 0 | 0 | NAN% | |
| FQ3 2023 (Sep 2023) | 0 | 0 | NAN% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Oct 2025) | $0B | $3.93B | $3925M | 100% |
| FQ2 2025 (Jun 2025) | $0B | $3.56B | $3561M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $3.49B | $3491M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $3.42B | $3416M | 100% |
| FQ4 2022 (Dec 2022) | $0B | $1.27B | $1274M | 100% |
| FQ1 2023 (Mar 2023) | $0B | $1.39B | $1391M | 100% |
| FQ2 2023 (Jun 2023) | $0B | $1.4B | $1401M | 100% |
| FQ3 2023 (Sep 2023) | $0B | $1.47B | $1470M | 100% |